MX349920B - Producción de principios farmacéuticos activos estériles. - Google Patents

Producción de principios farmacéuticos activos estériles.

Info

Publication number
MX349920B
MX349920B MX2014013238A MX2014013238A MX349920B MX 349920 B MX349920 B MX 349920B MX 2014013238 A MX2014013238 A MX 2014013238A MX 2014013238 A MX2014013238 A MX 2014013238A MX 349920 B MX349920 B MX 349920B
Authority
MX
Mexico
Prior art keywords
active pharmaceutical
pharmaceutical ingredients
production
sterile active
sterile
Prior art date
Application number
MX2014013238A
Other languages
English (en)
Other versions
MX2014013238A (es
Inventor
Leone Mario
Morosini Pierfrancesco
Original Assignee
Icrom Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icrom Spa filed Critical Icrom Spa
Publication of MX2014013238A publication Critical patent/MX2014013238A/es
Publication of MX349920B publication Critical patent/MX349920B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0029—Radiation
    • A61L2/0035—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/081—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20—Targets to be treated
    • A61L2202/21—Pharmaceuticals, e.g. medicaments, artificial body parts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a un proceso para preparar principios farmacéuticos activos (API) estériles, útiles en la preparación de producto estéril para uso oftálmico. El proceso comprende el tratamiento de esterilización con rayos gama del polvo de API en una atmosfera protectora.
MX2014013238A 2012-05-09 2012-05-09 Producción de principios farmacéuticos activos estériles. MX349920B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2012/000136 WO2013168186A1 (en) 2012-05-09 2012-05-09 Production of sterile active pharmaceutical ingredients

Publications (2)

Publication Number Publication Date
MX2014013238A MX2014013238A (es) 2015-04-08
MX349920B true MX349920B (es) 2017-08-21

Family

ID=46321406

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014013238A MX349920B (es) 2012-05-09 2012-05-09 Producción de principios farmacéuticos activos estériles.

Country Status (16)

Country Link
US (1) US10953115B2 (es)
EP (1) EP2846845B1 (es)
JP (1) JP6122485B2 (es)
KR (1) KR101966830B1 (es)
CN (1) CN104487099B (es)
BR (1) BR112014027885B1 (es)
CA (1) CA2872336C (es)
EA (1) EA028596B1 (es)
ES (1) ES2624250T3 (es)
HR (1) HRP20170529T1 (es)
HU (1) HUE034356T2 (es)
IN (1) IN2014DN09993A (es)
MX (1) MX349920B (es)
PL (1) PL2846845T3 (es)
PT (1) PT2846845T (es)
WO (1) WO2013168186A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210145836A1 (en) * 2012-05-09 2021-05-20 Icrom Spa Production of sterile active pharmaceutical ingredients
MX2018009497A (es) * 2016-02-05 2019-05-06 Innopharma Inc Proceso para fabricar una bolsa de infusion estable, lista para su uso para una formulacion sensible a la oxidacion.
PL3429555T3 (pl) * 2016-03-14 2020-08-24 Auxin Surgery Sa Preparat mesny i jego zastosowanie
BE1024110B1 (fr) * 2016-10-18 2017-11-16 Auxin Surgery Sa Dispositif, procédé et formulation pour dissection assistée de manière chimique
DE102017107124A1 (de) * 2017-04-03 2018-10-04 Ferton Holding S.A. Pulver zur Reinigung eines inneren Körperteils und/oder eines Implantats, Verfahren zur Herstellung eines solchen Pulvers und geeignete Verwendungen
IT202100006794A1 (it) 2021-03-22 2022-09-22 Icrom Srl Processo per preparare il verde indocianina

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2004553B1 (de) * 1970-02-02 1971-05-19 Fa B Braun, 3508 Melsungen Verfahren zur Herstellung von Leit schienen aus menschlichen oder tierischen Geweben zur Wiederherstellung beschädigter oder zerstörter spezifischer Gewebsteile im menschlichen und tierischen Korper
US6071904A (en) 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
US20030095890A1 (en) * 2001-09-24 2003-05-22 Shirley Miekka Methods for sterilizing biological materials containing non-aqueous solvents
WO2006124988A2 (en) * 2005-05-19 2006-11-23 Albiorex, Llc Terminal sterilization of injectable collagen products
US20090111856A1 (en) * 2006-05-09 2009-04-30 Mikael Brulls Parenteral Formulation Comprising Proton Pump Inhibitor Sterilized in its Final Container by Ionizing Radiation
BRPI0714526A2 (pt) * 2006-08-24 2013-04-30 Univ Tennessee Res Foundation acilanilidas substituÍdas e seus mÉtodos de uso
GB0626021D0 (en) * 2006-12-29 2007-02-07 Insense Ltd The stabilisation of proteins
WO2009026473A2 (en) * 2007-08-21 2009-02-26 Hollis-Eden Pharmaceuticals, Inc. Stabilized therapeutic compositions and formulations
EP2394637A1 (en) 2010-05-21 2011-12-14 Zaklady Farmaceutyczne Polpharma SA Process for obtaining sterile brinzolamide suspensions

Also Published As

Publication number Publication date
WO2013168186A1 (en) 2013-11-14
JP6122485B2 (ja) 2017-04-26
KR20150024821A (ko) 2015-03-09
HRP20170529T1 (hr) 2017-06-16
KR101966830B1 (ko) 2019-04-08
CN104487099B (zh) 2017-06-20
IN2014DN09993A (es) 2015-08-14
HUE034356T2 (en) 2018-02-28
MX2014013238A (es) 2015-04-08
PT2846845T (pt) 2017-06-02
EA028596B1 (ru) 2017-12-29
CA2872336A1 (en) 2013-11-14
BR112014027885B1 (pt) 2022-07-26
JP2015523327A (ja) 2015-08-13
BR112014027885A2 (pt) 2017-06-27
US20150141412A1 (en) 2015-05-21
EP2846845B1 (en) 2017-03-01
EP2846845A1 (en) 2015-03-18
EA201491845A1 (ru) 2015-02-27
CA2872336C (en) 2019-08-13
US10953115B2 (en) 2021-03-23
ES2624250T3 (es) 2017-07-13
CN104487099A (zh) 2015-04-01
PL2846845T3 (pl) 2017-07-31

Similar Documents

Publication Publication Date Title
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
TN2015000278A1 (en) Autotaxin inhibitors
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
PH12015502539A1 (en) Cenicriviroc compositions and methods of making and using the same
MX2013001402A (es) Proceso para preparar tubulisinas.
NZ709260A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
MX366899B (es) Nuevos compuestos.
MX349004B (es) Nuevos compuestos.
MX349920B (es) Producción de principios farmacéuticos activos estériles.
IN2015DN01165A (es)
TN2014000131A1 (en) Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments
TN2015000007A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
MX2015007731A (es) Formulacion farmaceutica que comprende ciclesonida.
MX2016006544A (es) Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas.
MX2013010415A (es) Tratamiento de la atrofia vaginal con nueva indicacion para la mirra.
PL2996675T3 (pl) Formulacja farmaceutyczna, sposób wytwarzania formulacji farmaceutycznej i roztwór do infuzji oraz ich zastosowanie jako wyrobu medycznego i/lub leku
PH12015501179A1 (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine
WO2013109202A3 (en) Pharmaceutical compounds comprising cefetamet
IN2014MU01178A (es)

Legal Events

Date Code Title Description
FG Grant or registration